Author: Ozdemir V.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.24, Iss.2, 2001-01, pp. : 75-85
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Internet and Drug Safety: What are the Implications for Pharmacovigilance?
By Cobert B.
Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. :
What is Drug Safety?: Celebrating 20 Years of the Drug Safety Journal
Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. :
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
Pharmacogenetics: The Therapeutic Drug Monitoring of the Future?
By Ensom M.H.H.
Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. :